TECH OUTLOOKTECH OUTLOOKDECEMBER - 20211December - 2 - 2021$15www.pharmatechoutlook.comIMMUNOTHERAPYE DI T I O NTAILORED HIGH AFFINITY FUNCTIONAL ANTIBODIES AGAINST HARD TO DRUG TARGETS IN CANCER AND PAINEUROPE SPECIALSreesha P Srinivasa, PH.D. Chief Development Officer (CDO)
Page 2 >